[Effect of phenofibrate on serum cholesterol and triglyceride concentration in patients with primary hyperlipoproteinemia].
D000328:Adult; D000924:Anticholesteremic Agents; D002784:Cholesterol / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D005260:Female; D011345:Fenofibrate / Q000008:administration & dosage*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D006953:Hyperlipoproteinemia Type IV / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011422:Propionates / Q000008:administration & dosage*; D014280:Triglycerides / Q000097:blood*
D000924:Anticholesteremic Agents; D011422:Propionates; D014280:Triglycerides; D002784:Cholesterol; D011345:Fenofibrate
Wpływ fenofibratu na stezenie cholesterolu i trójglicerydów w surowicy krwi osób z pierwotna hiperlipoproteidemia.